semaglutide patent expiry us 2031 weight-loss drug has expired in India, Indian pharmaceutical has wasted no-time to announce generics. What is the most pressing concern about semaglutide generics in India? ✅️Use without prescription is risky Abel + Imray | Ozempic®

Previous studies, while inconclusive, have raised concerns that the use of GLP-1 drugs lead to a higher rate of early worsening of DR, especially in patients with pre-existing retinopathy or those who experience rapid blood sugar improvement

Recovery from physical activity remains enhanced, allowing consistent exercise programming

Setting realistic expectations prevents frustration and keeps you committed for the long-term treatment course that meaningful weight loss requires

The phase 2 study to evaluate the efficacy, safety and tolerability of maridebart cafraglutide is currently ongoing (ClinicalTrials.gov number, NCT05669599)